Clinical Trial Update: Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects (301) [Phase 3]

View source ↗

Summary

Phase 3 trial update on IDP-124 Lotion for moderate to severe atopic dermatitis in adults and children; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• IDP-124 Lotion (IDP-124 lotion)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2023-05-08